Clinical strategies for expansion of haematopoietic stem cells (original) (raw)

• Osawa, M., Hanada, K., Hamada, H. & Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242–245 (1996).
  Article CAS PubMed Google Scholar
• Thomas, E. D., Lochte, H. L. Jr, Cannon, J. H., Sahler, O. D. & Ferrebee, J. W. Supralethal whole body irradiation and isologous marrow transplantation in man. J. Clin. Invest. 38, 1709–1716 (1959).
  Article CAS PubMed PubMed Central Google Scholar
• Gaziev, J. & Lucarelli, G. Stem cell transplantation for hemoglobinopathies. Curr. Opin. Pediatr. 15, 24–31 (2003).
  Article PubMed Google Scholar
• Cashman, J. D. et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89, 4307–4316 (1997).
  Article CAS PubMed Google Scholar
• Hiramatsu, H. et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/_γc_null mice model. Blood 102, 873–880 (2003).
  Article CAS PubMed Google Scholar
• Bodine, D. M., Karlsson, S. & Nienhuis, A. W. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc. Natl Acad. Sci. USA 86, 8897–8901 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Bodine, D. M., Orlic, D., Birkett, N. C., Seidel, N. E. & Zsebo, K. M. Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6, and in vivo in Sl/Sl d mice as a single factor. Blood 79, 913–919 (1992).
  Article CAS PubMed Google Scholar
• Petzer, A. L., Zandstra, P. W., Piret, J. M. & Eaves, C. J. Differential cytokine effects on primitive (CD34+CD38−) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J. Exp. Med. 183, 2551–2558 (1996).
  Article CAS PubMed Google Scholar
• Bhatia, M. et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186, 619–624 (1997). This paper shows that human HSCs can be moderately expanded for short periods of time when cultured in an appropriate combination of cytokines, but longer periods of culture result in a progressive loss of repopulating HSCs, as defined using an immunodeficient mouse model of human HSC engraftment.
  Article CAS PubMed PubMed Central Google Scholar
• Glimm, H. & Eaves, C. J. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 94, 2161–2168 (1999).
  Article CAS PubMed Google Scholar
• Gerber, H. P. et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417, 954–958 (2002).
  Article CAS PubMed Google Scholar
• de Haan, G. et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev. Cell 4, 241–251 (2003).
  Article CAS PubMed Google Scholar
• Karanu, F. N. et al. The Notch ligand Jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192, 1365–1372 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003).
  CAS PubMed Google Scholar
• Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836–841 (2003).
  Article CAS PubMed Google Scholar
• Arai, F. et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149–161 (2004).
  Article CAS PubMed Google Scholar
• Varnum-Finney, B. et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nature Med. 6, 1278–1281 (2000).
  Article CAS PubMed Google Scholar
• Stier, S., Cheng, T., Dombkowski, D., Carlesso, N. & Scadden, D. T. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99, 2369–2378 (2002).
  Article CAS PubMed Google Scholar
• Kumano, K. et al. Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression. Blood 98, 3283–3289 (2001).
  Article CAS PubMed Google Scholar
• Magli, M. C., Largman, C. & Lawrence, H. J. Effects of HOX homeobox genes in blood cell differentiation. J. Cell. Physiol. 173, 168–177 (1997).
  Article CAS PubMed Google Scholar
• Sauvageau, G. et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9, 1753–1765 (1995). This is the first description of HSC expansion in transplanted mice using a Hoxb4 -containing retroviral vector. HSC expansion is still responsive to normal control mechanisms and is limited after normal HSC numbers have been regenerated.
  Article CAS PubMed Google Scholar
• Krosl, J. et al. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1. Oncogene 16, 3403–3412 (1998).
  Article CAS PubMed Google Scholar
• DiMartino, J. F. et al. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98, 618–626 (2001).
  Article CAS PubMed Google Scholar
• Krosl, J., Beslu, N., Mayotte, N., Humphries, R. K. & Sauvageau, G. The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18, 561–571 (2003).
  Article CAS PubMed Google Scholar
• Beslu, N. et al. Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. Blood 29 June 2004 (doi:10. 1182/blood-2004-04-1653).
• Brun, A. C. et al. _Hoxb4_-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 103, 4126–4133 (2004).
  Article CAS PubMed Google Scholar
• Antonchuk, J., Sauvageau, G. & Humphries, R. K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109, 39–45 (2002). This paper describes a 2,000-fold expansion of mouse HSCs in culture after transduction with a Hoxb4 -containing retroviral vector. This degree of HSC expansion far exceeds the levels that have been obtained using any other method.
  Article CAS PubMed Google Scholar
• Krosl, J. et al. In vitro expansion of hematopoietic stem cells by recombinant TAT–HOXB4 protein. Nature Med. 9, 1428–1432 (2003).
  Article CAS PubMed Google Scholar
• Amsellem, S. et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nature Med. 9, 1423–1427 (2003). This paper shows that a recombinant HOXB4 protein that can penetrate the cell membrane can be used to expand human HSCs in culture. This paper supports the rationale that transcription factors that increase self-renewal can be used as growth factors in culture media.
  Article CAS PubMed Google Scholar
• Antonchuk, J., Sauvageau, G. & Humphries, R. K. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp. Hematol. 29, 1125–1134 (2001).
  Article CAS PubMed Google Scholar
• Malech, H. L. et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc. Natl Acad. Sci. USA 94, 12133–12138 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Dunbar, C. E. et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum. Gene Ther. 9, 2629–2640 (1998).
  Article CAS PubMed Google Scholar
• Mardiney, M. et al. Enhanced host defense after gene transfer in the murine p47phox- deficient model of chronic granulomatous disease. Blood 89, 2268–2275 (1997).
  Article CAS PubMed Google Scholar
• Bjorgvinsdottir, H. et al. Retroviral-mediated gene transfer of gp91 phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood 89, 41–48 (1997).
  Article CAS PubMed Google Scholar
• Allay, J. A. et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med. 4, 1136–1143 (1998). This paper provides definitive proof, using a mouse model, that drug-resistance genes can be used to select HSCs in vivo.
  Article CAS PubMed Google Scholar
• Persons, D. A. et al. Successful treatment of murine β-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells. Blood 102, 506–513 (2003).
  Article CAS PubMed Google Scholar
• Zielske, S. P. & Gerson, S. L. Lentiviral transduction of P140K MGMT into human CD34+ hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro. Mol. Ther. 5, 381–387 (2002).
  Article CAS PubMed Google Scholar
• Davis, B. M., Koc, O. N. & Gerson, S. L. Limiting numbers of G156A O6-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood 95, 3078–3084 (2000).
  Article CAS PubMed Google Scholar
• Sorrentino, B. P. Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs. Nature Rev. Cancer 2, 431–441 (2002).
  Article CAS Google Scholar
• Sawai, N., Persons, D. A., Zhou, S., Lu, T. & Sorrentino, B. P. Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression. Mol. Ther. 8, 376–384 (2003). This paper shows that in vivo selection of HSCs with cytotoxic drugs results in a decrease in the overall number of HSCs. This reduction can be overcome by co-expression of HOXB4, which also results in an increase in the efficiency of the selection process.
  Article CAS PubMed Google Scholar
• Szymczak, A. L. et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nature Biotechnol. 22, 589–594 (2004).
  Article CAS Google Scholar
• Perkins, A. C. & Cory, S. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J. 12, 3835–3846 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Thorsteinsdottir, U. et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol. Cell. Biol. 17, 495–505 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Brun, A. C., Fan, X., Bjornsson, J. M., Humphries, R. K. & Karlsson, S. Enforced adenoviral vector-mediated expression of HOXB4 in human umbilical cord blood CD34+ cells promotes myeloid differentiation but not proliferation. Mol. Ther. 8, 618–628 (2003).
  Article CAS PubMed Google Scholar
• Schiedlmeier, B. et al. High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation. Blood 101, 1759–1768 (2003).
  Article CAS PubMed Google Scholar
• Giles, R. H., van Es, J. H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1–24 (2003).
  CAS PubMed Google Scholar
• Muller-Tidow, C. et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol. Cell. Biol. 24, 2890–2904 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Austin, T. W., Solar, G. P., Ziegler, F. C., Liem, L. & Matthews, W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89, 3624–3635 (1997).
  Article CAS PubMed Google Scholar
• van den Berg, D. J., Sharma, A. K., Bruno, E. & Hoffman, R. Role of members of the Wnt gene family in human hematopoiesis. Blood 92, 3189–3202 (1998).
  Article CAS PubMed Google Scholar
• Murdoch, B. et al. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc. Natl Acad. Sci. USA 100, 3422–3427 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409–414 (2003). This study shows that mouse HSCs can be expanded in culture after transduction with an activated β-catenin gene. It also shows that the WNT-signalling pathway is used by HSCs.
  Article CAS PubMed Google Scholar
• Zhu, A. J. & Watt, F. M. β-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development 126, 2285–2298 (1999).
  Article CAS PubMed Google Scholar
• Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet. 19, 379–383 (1998).
  Article CAS PubMed Google Scholar
• Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448–452 (2003). This study tested whether soluble WNT3A is an HSC growth factor in culture. By culturing single cells in the presence of stem-cell factor and WNT3A, considerable expansion of mouse HSCs was obtained.
  Article CAS PubMed Google Scholar
• Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  Article CAS PubMed Google Scholar
• Cheng, T. et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804–1808 (2000). This paper shows that the HSC pool size is increased in p21-deficient mice owing to an increase in HSC proliferation. These data provide clear evidence that cyclin-dependent kinase inhibitors regulate HSC kinetics.
  Article CAS PubMed Google Scholar
• Stier, S. et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 102, 1260–1266 (2003).
  Article CAS PubMed Google Scholar
• Cheng, T., Rodrigues, N., Dombkowski, D., Stier, S. & Scadden, D. T. Stem cell repopulation efficiency but not pool size is governed by p27kip1. Nature Med. 6, 1235–1240 (2000).
  Article CAS PubMed Google Scholar
• Dao, M. A., Taylor, N. & Nolta, J. A. Reduction in levels of the cyclin-dependent kinase inhibitor p27kip-1 coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc. Natl Acad. Sci. USA 95, 13006–13011 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Dao, M. A., Hwa, J. & Nolta, J. A. Molecular mechanism of transforming growth factor β-mediated cell-cycle modulation in primary human CD34+ progenitors. Blood 99, 499–506 (2002).
  Article CAS PubMed Google Scholar
• Yuan, Y., Shen, H., Franklin, D. S., Scadden, D. T. & Cheng, T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nature Cell Biol. 6, 436–442 (2004). This paper shows that bone marrow from p18-deficient mice contains more HSCs owing to increased self-renewal divisions. Unlike loss of p21 expression, loss of p18 expression does not lead to the exhaustion of HSCs with time.
  Article CAS PubMed Google Scholar
• Park, I. K., Morrison, S. J. & Clarke, M. F. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175–179 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lessard, J. & Sauvageau, G. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis. Exp. Hematol. 31, 567–585 (2003).
  Article CAS PubMed Google Scholar
• Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164–168 (1999).
  Article CAS PubMed Google Scholar
• Lowe, S. W. & Sherr, C. J. Tumor suppression by Ink4a–Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77–83 (2003).
  Article CAS PubMed Google Scholar
• Park, I. K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302–305 (2003). This paper shows that, in maturing adult mice, loss of the BMI1 polycomb repressor results in the progressive loss of HSCs with time. This phenotype occurs because of the activation of p16 and p19 ARF expression by HSCs.
  Article CAS PubMed Google Scholar
• Molofsky, A. V. et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962–967 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255–260 (2003).
  Article CAS PubMed Google Scholar
• Roux, E. et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 87, 3984–3992 (1996).
  Article CAS PubMed Google Scholar
• Dumont-Girard, F. et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 92, 4464–4471 (1998).
  Article CAS PubMed Google Scholar
• Douek, D. C. et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355, 1875–1881 (2000).
  Article CAS PubMed Google Scholar
• Roux, E. et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96, 2299–2303 (2000).
  Article CAS PubMed Google Scholar
• Lang, P. et al. Clinical scale isolation of highly purified peripheral CD34+ progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant. 24, 583–589 (1999).
  Article CAS PubMed Google Scholar
• Handgretinger, R. et al. Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 27, 777–783 (2001). This paper describes the importance of using high doses of CD34+ stem cells when using parental donors for paediatric transplants.
  Article CAS PubMed Google Scholar
• Lang, P. et al. Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant. 33, 25–32 (2004).
  Article CAS PubMed Google Scholar
• Gluckman, E. et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174–1178 (1989).
  Article CAS PubMed Google Scholar
• Gluckman, E. Hematopoietic stem-cell transplants using umbilical-cord blood. N. Engl. J. Med. 344, 1860–1861 (2001).
  Article CAS PubMed Google Scholar
• Wagner, J. E. et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100, 1611–1618 (2002).
  Article CAS PubMed Google Scholar
• Shpall, E. J. et al. Transplantation of ex vivo expanded cord blood. Biol. Blood Marrow Transplant. 8, 368–376 (2002).
  Article PubMed Google Scholar
• Fernandez, M. N. et al. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant. 28, 355–363 (2001).
  Article CAS PubMed Google Scholar
• Miller, D. G., Adam, M. A. & Miller, A. D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239–4242 (1990).
  CAS PubMed PubMed Central Google Scholar
• Moscow, J. A. et al. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 94, 52–61 (1999).
  Article CAS PubMed Google Scholar
• Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267 (1996).
  Article CAS PubMed Google Scholar
• Chinnasamy, D. et al. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 96, 1309–1316 (2000).
  Article CAS PubMed Google Scholar
• Hacein-Bey-Abina, S. et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185–1193 (2002).
  Article CAS PubMed Google Scholar
• Aiuti, A. et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410–2413 (2002).
  Article CAS PubMed Google Scholar
• Bunting, K. D., Sangster, M. Y., Ihle, J. N. & Sorrentino, B. P. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nature Med. 4, 58–64 (1998).
  Article CAS PubMed Google Scholar
• Hacein-Bey-Abina, S. et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255–256 (2003).
  Article PubMed Google Scholar
• Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419 (2003). This paper describes a molecular analysis of two cases of T-cell leukaemia that occurred in a human trial of gene therapy for XSCID. Both showed insertional activation of the LMO2 oncogene by the retroviral vector.
  Article CAS PubMed Google Scholar
• Kiem, H. P. et al. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Mol. Ther. 9, 389–395 (2004).
  Article CAS PubMed Google Scholar
• Jin, L. et al. In vivo selection using a cell-growth switch. Nature Genet. 26, 64–66 (2000).
  Article CAS PubMed Google Scholar
• Jin, L. et al. Targeted expansion of genetically modified bone marrow cells. Proc. Natl Acad. Sci. USA 95, 8093–8097 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kohn, D. B. et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol. Ther. 8, 180–187 (2003).
  Article CAS PubMed Google Scholar
• Baum, C. et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101, 2099–2114 (2003). An excellent review of the safety issues associated with HSC-targeted gene therapy. There is a detailed consideration of how safety can be improved through modified gene-therapy vectors and protocols.
  Article CAS PubMed Google Scholar
• Kondo, M., Weissman, I. L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672 (1997).
  Article CAS PubMed Google Scholar
• Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197 (2000).
  Article CAS PubMed Google Scholar